Current and Novel Treatments for Ulcerative Colitis

Ulcerative colitis and Crohn’s disease are defined by a common term of inflammatory bowel disease. These chronic diseases result in significant morbidity and mortality. While there are no cures for these diseases, the last two decades have been a period of major advancement in our understanding of the biology of intestinal inflammation. This can be attributed to a steadily increasing number of experimental animal models with some clinical manifestation similar to those observed in human inflammatory bowel disease. These experimental animal models have also contributed greatly to our current understanding of the immunological, pathological and physiological features of chronic intestinal inflammation. However, specific causes of ulcerative colitis and Crohn’s disease remain unknown. Conventional treatments for the disease include corticosteroids and immunosuppressives, however treatments in many patients are not entirely effective with many therapies associated with significant adverse effects. Thus, treatments that are effective and have little or no side effects remain an unmet need. There are numerous emerging therapeutic strategies which may be useful in the alleviation of chronic intestinal inflammation and this chapter will focus on novel therapies that may be effective for ulcerative colitis in the future.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.5772/25592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ulcerative Colitis from Genetics to Complications

  2012cited by this paper
• Marginal zinc deficiency exacerbates experimental colitis induced by dextran sulfate sodium in rats.

  2011cited by this paper
• Treatment of inflammatory bowel disease (IBD)

  2011cited by this paper
• Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis.

  2011cited by this paper
• Randomised clinical trial: herbal extract HMPL‐004 in active ulcerative colitis – a double‐blind comparison with sustained release mesalazine

  2011cited by this paper
• Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.

  2011cited by this paper
• Maintenance of remission in inflammatory bowel disease using omega‐3 fatty acids (fish oil): A systematic review and meta‐analyses

  2011influential reference
• Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)

  2010cited by this paper
• Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid‐dependent cases

  2010cited by this paper
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Exacerbation of Oxazolone Colitis by Infection with the Helminth Hymenolepis diminuta Involvement of IL-5 and Eosinophils

  2010cited by this paper
• American Ginseng Suppresses Colitis through p53-Mediated Apoptosis of Inflammatory Cells

  2010cited by this paper
• Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids.

  2010cited by this paper
• Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis

  2010cited by this paper
• Effect of Arctium lappa L. in the dextran sulfate sodium colitis mouse model.

  2010cited by this paper
• Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.

  2010cited by this paper
• Pulmonary, Gastrointestinal and Urogenital Pharmacology Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice

  2010cited by this paper
• Do studies in humans better depict Th17 cells?

  2009cited by this paper
• T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

  2009cited by this paper
• Foxp3+ regulatory T cells: differentiation, specification, subphenotypes

  2009cited by this paper
• Dendritic cells in intestinal homeostasis and disease.

  2009cited by this paper
• Biological therapies for inflammatory bowel diseases.

  2009cited by this paper
• Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective

  2009cited by this paper
• Probiotics and immunity

  2009cited by this paper
• Infection with Hymenolepis diminuta Is More Effective than Daily Corticosteroids in Blocking Chemically Induced Colitis in Mice

  2009cited by this paper
• Crocetin Reduces TNBS-Induced Experimental Colitis in Mice by Downregulation of NFkB

  2009cited by this paper
• Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice

  2009influential reference
• Heterogeneity of human effector CD4+ T cells

  2009cited by this paper
• Response of cell cycle/stress-related protein expression and DNA damage upon treatment of CaCo2 cells with anthocyanins

  2008cited by this paper
• Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

  2008cited by this paper
• Effect of n‐3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis

  2008cited by this paper
• Fish oil in critical illness

  2008cited by this paper
• Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.

  2008cited by this paper
• American ginseng suppresses inflammation and DNA damage associated with mouse colitis

  2008cited by this paper
• Rationale for probiotic treatment strategies in inflammatory bowel disease

  2008cited by this paper
• Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.

  2008cited by this paper
• Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis.

  2008cited by this paper
• Omega‐3 fatty acids exacerbate DSS‐induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts

  2008cited by this paper
• Microbial influences in inflammatory bowel diseases.

  2008cited by this paper
• Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2

  2008cited by this paper
• Oral oligofructose‐enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin

  2007cited by this paper
• Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis.

  2007cited by this paper
• Inflammation, cancer, and targets of ginseng.

  2007cited by this paper
• The Role of Zinc and Metallothionein in the Dextran Sulfate Sodium-Induced Colitis Mouse Model

  2007cited by this paper
• Phenotypic and functional features of human Th17 cells

  2007cited by this paper
• Helminths as governors of immune-mediated inflammation.

  2007cited by this paper
• Gnotobiotic Mouse Immune Response Induced by Bifidobacterium sp. Strains Isolated from Infants

  2007cited by this paper
• Th17 cells: effector T cells with inflammatory properties.

  2007cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats.

  2007cited by this paper
• Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair

  2007influential reference
• Pomegranate peel extract prevents liver fibrosis in biliary‐obstructed rats

  2007cited by this paper
• Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity

  2007cited by this paper
• Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells.

  2007influential reference
• Prebiotics in inflammatory bowel diseases

  2007cited by this paper
• Adiponectin deficiency protects mice from chemically induced colonic inflammation.

  2007cited by this paper
• Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy

  2007influential reference
• A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis

  2007influential reference
• Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.

  2007cited by this paper
• Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials

  2007cited by this paper
• Th17: an effector CD4 T cell lineage with regulatory T cell ties.

  2006cited by this paper
• Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

  2006cited by this paper
• Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin.

  2006cited by this paper
• Suppression of the Tumorigenic Phenotype in Human Oral Squamous Cell Carcinoma Cells by an Ethanol Extract Derived From Freeze-Dried Black Raspberries

  2006cited by this paper
• Evolving knowledge and therapy of inflammatory bowel disease

  2006cited by this paper
• Critical appraisal of the current practice in murine TNBS-induced colitis.

  2006cited by this paper
• Effect of adiponectin on murine colitis induced by dextran sulfate sodium.

  2006cited by this paper
• Chemical compositions, antioxidant capacities, and antiproliferative activities of selected fruit seed flours.

  2006cited by this paper
• Effects of Ginkgo biloba Extract on Inflammatory Mediators (SOD, MDA, TNF-α, NF-κBp65, IL-6) in TNBS-Induced Colitis in Rats

  2006cited by this paper
• Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions.

  2006cited by this paper
• Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways

  2006influential reference
• Characteristics of intestinal dendritic cells in inflammatory bowel diseases.

  2005influential reference
• Anti-diabetic action of Punica granatum flower extract: activation of PPAR-gamma and identification of an active component.

  2005cited by this paper
• Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease.

  2005influential reference
• Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.

  2005cited by this paper
• Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice

  2005cited by this paper
• Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn’s disease

  2005cited by this paper
• Intestinal macrophages: unique effector cells of the innate immune system

  2005cited by this paper
• Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors.

  2005cited by this paper
• Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV

  2005cited by this paper
• Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 mice

  2005cited by this paper
• Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.

  2005cited by this paper
• Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial.

  2005cited by this paper
• Preventative Effects of Lactulose in the Trinitrobenzenesulphonic Acid Model of Rat Colitis

  2005influential reference
• Dietary N‐3 Polyunsaturated Fatty Acids Reduce Disease and Colonic Proinflammatory Cytokines in a Mouse Model of Colitis

  2005cited by this paper
• Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

  2005cited by this paper
• An integrated view of suppressor T cell subsets in immunoregulation.

  2004cited by this paper
• Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

  2004cited by this paper
• Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

  2004cited by this paper
• PASSCLAIM1—Gut health and immunity

  2004cited by this paper
• Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis.

  2004cited by this paper
• Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

  2004cited by this paper
• Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases.

  2004cited by this paper
• Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease.

  2004cited by this paper
• Protective Effect of Lactulose on Dextran Sulfate Sodium-Induced Colonic Inflammation in Rats

  2004cited by this paper
• Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

  2004cited by this paper
• Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels.

  2004cited by this paper
• The Effect of Ginkgo Biloba in Isolated Ischemic/Reperfused Rat Heart: A Link between Vitamin E Preservation and Prostaglandin Biosynthesis

  2004cited by this paper
• The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence.

  2004cited by this paper
• Impact of Dextran Sulfate Sodium Load on the Severity of Inflammation in Experimental Colitis

  2004cited by this paper
• Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren.

  2004cited by this paper

• F-actin dynamics couples sphingolipid metabolism to epithelial barrier integrity in chronic colitis

  2026cites this paper
• Polyphenols mitigating inflammatory mechanisms in inflammatory bowel disease (IBD): focus on the NF-ƙB and JAK/STAT pathways

  2024cites this paper
• Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis

  2023cites this paper
• Proof of Concept for a Deep Learning Algorithm for Identification and Quantification of Key Microscopic Features in the Murine Model of DSS-Induced Colitis

  2021cites this paper
• Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer

  2021cites this paper
• Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease

  2017cites this paper
• Animal Models of Inflammatory Bowel Disease

  2017cites this paper
• Appropriateness of reference genes for normalizing messenger RNA in mouse 2,4-dinitrobenzene sulfonic acid (DNBS)-induced colitis using quantitative real time PCR

  2017cites this paper
• Pharmacological modulation of inflammation associated with inflammatory bowel disease : - study in an animal model

  2016cites this paper
• Modulation of PPARγ and TNFα by emu oil and glycyrrhizin in ulcerative colitis

  2015cites this paper
• Effect of chenodeoxycholic acid and sodium hydrogen sulfide in dinitro benzene sulfonic acid (DNBS) — Induced ulcerative colitis in rats

  2015cites this paper
• Animal models of inflammatory bowel disease: a review

  2014influential citation
• Emu oil promotes intestinal repair in rat models of enteric inflammation.

  2013cites this paper